| Technology evolution: is it survival of the fittest? | |
| | |
MedLine Citation:
|
PMID: 20697074 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control costs has become clear, this situation is undesirable. The assessment of efficacy can, however, be very difficult, and the control of financial aspects is likewise problematic. In this article, we address these problems and suggest potential solutions, using proton radiotherapy as an example that may be relevant to the development of other medical devices. |
| | |
Authors:
|
Anthony Zietman; Michael Goitein; Joel E Tepper |
Related Documents
:
|
15966144 - How to select a sterilisation process. 1634264 - The impact of standards. 2834214 - Paranormal health claims. 3638344 - Intrauterine treatment of fetal tachycardia. 6417254 - Risk acceptance criteria and their development. 1641534 - Medical laboratory technologists' perception of professional self. a study of swedish m... |
Publication Detail:
|
Type: Journal Article Date: 2010-08-09 |
Journal Detail:
|
Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Volume: 28 ISSN: 1527-7755 ISO Abbreviation: J. Clin. Oncol. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-17 Completed Date: 2010-10-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8309333 Medline TA: J Clin Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 4275-9 Citation Subset: IM |
Affiliation:
|
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Clinical Trials as Topic Cost Control Diffusion of Innovation* Equipment Design Evidence-Based Medicine Health Care Costs Humans Patient Selection Protons / therapeutic use* Radiotherapy / economics, instrumentation* Technology Transfer* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Protons |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Active Surveillance: Is There a Need for Better Risk Stratification at the Outset?
Next Document: Reply to P. Singh et al.